BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simon M, Bosset PO, Rouanne M, Benhamou S, Radulescu C, Molinié V, Neuzillet Y, Paoletti X, Lebret T. Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score. PLoS One 2019;14:e0211721. [PMID: 30811419 DOI: 10.1371/journal.pone.0211721] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Reyes RM, Rios E, Barney S, Hugen CM, Michalek JE, Lotan Y, Messing EM, Svatek RS. A Randomized Feasibility Trial Comparing Surveillance Regimens for Patients with Low and Low-Intermediate Risk Non-Muscle Invasive Bladder Cancer. Bladder Cancer 2021;7:285-95. [PMID: 34621937 DOI: 10.3233/blc-201535] [Reference Citation Analysis]
2 Shah P, Kim FJ, Mian BM. Genitourinary cancer management during a severe pandemic: Utility of rapid communication tools and evidence-based guidelines. BJUI Compass 2020;1:45-59. [PMID: 32537615 DOI: 10.1002/bco2.18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Broughton EI, Gooden KM, Mycock KL, Rajkovic I, Taylor-stokes G. Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). BMC Urol 2022;22. [DOI: 10.1186/s12894-022-00959-z] [Reference Citation Analysis]
4 Russell B, Kotecha P, Thurairaja R, Nair R, Malde S, Kumar P, Khan MS. Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices. Transl Androl Urol 2021;10:2750-61. [PMID: 34295760 DOI: 10.21037/tau-20-1363] [Reference Citation Analysis]
5 Tschirdewahn S, Harke NN, Hirner L, Stagge E, Hadaschik B, Eisenhardt A. Narrow-band imaging assisted cystoscopy in the follow-up of patients with transitional cell carcinoma of the bladder: a randomized study in comparison with white light cystoscopy. World J Urol 2020;38:1509-15. [PMID: 31471739 DOI: 10.1007/s00345-019-02926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Baart VM, van der Horst G, Deken MM, Bhairosingh SS, Schomann T, Sier VQ, van der Mark MH, Iamele L, de Jonge H, Resnati M, Mazar AP, Pelger RCM, van der Pluijm G, Kuppen PJK, Vahrmeijer AL, Sier CFM. A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma. Eur J Cancer 2021;146:11-20. [PMID: 33561783 DOI: 10.1016/j.ejca.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bree KK, Shan Y, Hensley PJ, Lobo N, Hu C, Tyler DS, Chamie K, Kamat AM, Williams SB. Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013. JAMA Netw Open 2022;5:e223050. [PMID: 35302627 DOI: 10.1001/jamanetworkopen.2022.3050] [Reference Citation Analysis]
8 Miyake M, Nishimura N, Nakai Y, Fujii T, Owari T, Hori S, Morizawa Y, Gotoh D, Anai S, Torimoto K, Tanaka N, Hirao Y, Fujimoto K. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method. Diagnostics (Basel) 2021;11:185. [PMID: 33525423 DOI: 10.3390/diagnostics11020185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mian BM, Siddiqui S, Ahmad AE. Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes. Urol Oncol 2021;39:258-67. [PMID: 33129674 DOI: 10.1016/j.urolonc.2020.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]